Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss differences among platforms for genetic profiling of metastatic non–small cell lung cancer in terms of sensitivity, specificity, and multiplex capability, as well as detection of complex genomic alterations.
ReNeuron breakthrough – Exosome tech delivers therapeutic proteins to hard to access region of brain
October 12, 2021
September 24, 2021
Good things come in small packages: roles of exosomes as therapy delivery tools, therapeutic targets and potential biomarkers
March 23, 2021
December 3, 2020